Tue, March 28th 2023
ProtonDx's proprietary rapid multipathogen test was a key diagnostic element used to test the Finnish cross-country skiers in The FIS Nordic World Ski Championships in Planica, Slovenia, in February - March 2023.
Dragonfly Respiratory Panel Reliably Identifies Five Most Common Causes of Respiratory Infections, Joins List of UK Approved Diagnostic Products
Mon, February 6th 2023
Rapid molecular point-of-care diagnostic system reliably detects SARS-CoV-2, Flu A, Flu B, RSV and Human Rhinovirus. Clinical test results for CTDA validation achieved 100% sensitivity and 100% specificity. UK approval follows CE-IVD mark.
ProtonDx Awarded £365,000 Defra and Innovate UK Grant to Develop Porcine Lung Disease Diagnostic
Fri, September 23rd 2022
Grant to develop automated, rapid point-of-need diagnostic to provide a sustainable and resilient revolution in detection and diagnosis of Porcine Respiratory Disease Complex (PRDC). Working in collaboration with Imperial College, farmers and industry experts to help address the global issue of rising antibiotic resistance.
ProtonDx Tackles Malaria Diagnosis
Fri, April 29th 2022
Lacewing, the futuristic lab-on-a-chip, diagnostic tool is one of eight initiatives promoted by Imperial College London to mark Malaria Day, 25 April, in order to demonstrate the College’s deep commitment to conquering malaria. Lacewing is being developed for health care applications by Imperial spin out company ProtonDx based at the College’s Translation and Innovation HUB (I-HUB), White City Campus.